Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension

Vascular Medicine

Volumn 3, Issue 2, 1998, Pages 138-144

  Cardillo, Carmine ^a   Panza, Julio A ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood vessels; Endothelium; Hypertension; Nitric oxide

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ATHEROSCLEROSIS; BLOOD VESSEL TONE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031786851     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836x9800300208     Document Type: Review

References (79)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-76.
2. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983; 53: 557-73.
3. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983; 5: 881-86.
4. Luscher TF, Vanhoutte PM. Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rats. Hypertension 1986; 8: II55-II60.
5. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8: II61-II66.
6. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9: 157-63.
7. Luscher TF, Aarhus LL, Vanhoutte PM. Indomethacin enhances the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat. Am J Hypertens 1990; 3: 55-58.
8. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
9. Linder L, Kiowski W, Buhler FR, Luscher TF. Direct evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81: 1762-67.
10. Yoshida M, Imaizumi T, Ando S et al. Impaired forearm vasodilatation by acetylcholine in patients with hypertension. Heart Vessels 1991; 6: 218-23.
11. Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992; 19: 809-15.
12. Treasure CB, Manoukian SV, Klein JL et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Rev 1992; 71: 776-81.
13. Taddei S, Virdis A, Mattel P, Salvelti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-33.
14. Treasure CB, Klein JL, Vita JA et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.
15. Falloon BJ, Heagerty AM. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994; 24: 16-23.
16. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994; 24: 499-505.
17. Nitenberg A, Antony I, Aptecar E, Arnoult F, Lerebours G. Impairment of flow-dependent coronary dilation in hypertensive patients. Demonstration by cold pressof test induced flow velocity increase. Am J Hypertens 1995; 8: 13S-18S.
18. Egashira K, Suzuki S, Hirooka Y et al. Impaired endothelium-dependent vasodilation of large epicajdial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 1995; 25: 201-06.
19. Kelm M, Preik M, Hafner DJ, Strauer BE. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension 1996; 27: 346-53.
20. Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci 1995; 88: 611-22.
21. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-40.
22. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis 1988; 30: 349-80.
23. Vane JR, Änggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
24. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-26.
25. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-66.
26. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96: 418-24.
27. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000.
28. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-31.
29. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-74.
30. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29: 274-79.
31. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand 1970; suppl 343: 1-56.
32. Folkow B. 'Structural factor' in primary and secondary hypertension. Hypertension 1990; 16: 89-101.
33. Doyle AE, Fraser JRE, Marshall RJ. Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sci 1959; 18: 441-54.
34. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80: 812-17.
35. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990; 67: 1301-08.
36. Cooke JP, Dzau J, Creager A. Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine. Basic Res Cardiol 1991; Suppl 2: 173-81.
37. Rossitch E Jr, Alexander E, Black PM, Cooke JP. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest 1991; 87: 1295-99.
38. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991; 83: 1057-62.
39. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-50.
40. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J CUn Invest 1992; 90: 1248-53.
41. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87: 1475-81.
42. Imaizumi T, Hirooka Y, Masaki H et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992; 20: 511-27.
43. Cooke JP, Dzau VJ. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 1997; 96: 379-82.
44. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Cooke JP. Asymmetric dimethylarginine: a novel risk factor for atherosclerosis [abstract]. Circulation 1997; 96: 132.
45. Stroes ESG, Kastelein JJ, Cosentino F, Erkelens DW, Wever R, Koomans HA, Luscher TF, Rabelink TJ. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99: 41-46.
46. Egashira K, Inou T, Yamada A et al. Heterogeneous effects of the endothelium-dependent vasodilators acetylcholine and substance P on the coronary circulation of patients with angiographically normal coronary arteries. Coron Artery Dis 1992; 3: 945-52.
47. Okumura K, Yasue H, Ishizaka H, Ogawa H, Fujii H, Yoshimura M, Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 1992; 20: 838-44.
48. Saito R, Nonaka S, Konishi H et al. Pharmacological properties of the tachykinin receptor subtype in the endothelial cell and vasodilation. Ann N Y Acad Sci 1991; 632: 457-59.
49. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol 1994; 23: 1610-16.
50. Bosaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 170-74.
51. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Cire Res 1988; 63: 903-10.
52. Komori K, Shimokawa H, Vanhoutte PM. Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries. J Vasc Surg 1989; 10: 318-25.
53. Shimokawa H, Flavahan NA. Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 1991; 83: 652-60.
54. Shimokawa H, Flavahan NA, Vanhoutte PM, Natural course of the impairment of endothelium-dependent relaxations in regenerating porcine endothelial cells: possible dysfunction of a pertussis toxin-sensitive G-protein. Circ Res 1990; 65: 740-53.
55. Flavahan NA. Atherosclerotic or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85: 1927-38.
56. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995; 91: 1732-38.
57. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA. A selective detect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998; 97: 851-56.
58. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension 1997; 30: 918-21.
59. Daves M, Chowienczyk PJ, Ritter JM. Effects if inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation 1997; 95: 2293-97.
60. Berridge MJ, Irvine RF. Inositol phosphate and cell signaling. Nature 1989; 341: 197-205.
61. Busse R, Fichtner H, Luckhoff A, Kohlhardt M. Hyperpolarization and increased free calcium in acetylcholine-stimulated endothelial cells. Am J Physiol 1988; 255: H965-H69.
62. Danthuluri NR, Cybulsky MI, Brock TA. Acetylcholine-induced calcium transients in primary cultures of rabbit aortic endothelial cells. Am J Physiol 1988; 255: H1549-H53.
63. Nathan C, Xie Q-W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-18.
64. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250: H822-H27.
65. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-56.
66. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-51.
67. Mugge A, Brandes RP, Boger RH et al. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 1994; 24: 994-98.
68. Mugge A, Helwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxation in cholesterol-fed rabbits. Circ Res 1991; 69: 1293-1300.
69. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erithrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-55.
70. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 1991; 88: 10045-48.
71. García CE, Kilcoyne CM, Cardillo C, Cannon RO, Quyyumi AA, Panza JA. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation of patients with essential hypertension. Hypertension 1995; 26: 863-68.
72. White CW, Brock TA, Chang LY et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 1044-48.
73. Friedl HP, Till GO, Ryan US, Ward PA. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J 1989; 3: 2512-18.
74. Bulkey OB. Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. Lancet 1994; 344: 934-36.
75. McKelvey G, Hollwarth E, Glanger N, Engerson D, Landler U, Jones P. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol 1988; 27: G753-G60.
76. Cardillo C, Kilcoyne CM, Cannon RO, Quyyrnni AA, Panza JA. Xanthine oxidase inhibition improves endothelium-dependent vasodilation in hypercholesterolemic but not in hypertensive patients. Hypertension 1997; 30: 57-63.
77. Taddei S, Virdis A, Mattei P et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94: 1298-1303.
78. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993; 21: 1145-51.
79. Kiowski W, Under L, Nuesch R, Martina B. Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension 1996; 27: 371-76.